Background: Matrix Metalloproteinase -9, is involved in fear associated memory formation, wherein transcriptional regulation is poorly known.
SUMMARY
Memory formation requires learning based molecular and structural changes in neurons, whereas matrix metalloproteinase (MMP)-9 is involved in the synaptic plasticity by cleaving extracellular matrix proteins and thus is associated with learning processes in the mammalian brain. As the mechanisms of MMP-9 transcription in the brain are poorly understood, this study aimed at elucidating regulation of MMP-9 gene expression in the mouse brain after fear learning. We show herein that contextual fear conditioning markedly increases MMP-9 transcription, followed by enhanced enzymatic levels in the three major brain structures implicated in fear learning, i.e., the amygdala, hippocampus and prefrontal cortex. To reveal the role of AP-1 transcription factor in MMP-9 gene expression, we have used reporter gene constructs with specifically mutated AP-1 gene promoter sites. The constructs were introduced into the medial prefrontal cortex of neonatal mouse pups by electroporation, and the regulation of MMP-9 transcription was studied after contextual fear conditioning in the adult animals. Learned fear allows animals to survive in their natural environment. Three major structures of the mammalian brain have been implicated in fear learning, i.e., the prefrontal cortex (PFC), amygdala (Amy), and hippocampus (Hipp) (1) . It is also known that experience modifies functional circuits in the brain (2) and that changes in the morphology of dendritic spines might be involved in synaptic plasticity related to learning and memory (3, 4) . Notably, synaptic plasticity involves remodeling of extracellular matrix in the brain (5) (6) (7) (8) .
Matrix metalloproteinase (MMP)-9 is recently extensively studied extracellular endopeptidase that cleaves extracellular matrix (ECM) proteins to modulate synaptic plasticity and thus it has been associated with learning process in mammalian brain (8) (9) (10) . Although MMP-9 expression and activity have been linked to such brain pathologies as ischemia, gliomas or epilepsy (11) (12) (13) , MMP-9 can also modify basic brain circuitry during contextual fear learning and long term memory formation (8, 14, 15) . Long lasting forms of synaptic plasticity and long-term memory formation require new mRNA and protein synthesis (10, 15) . It has been established that MMP-9 mRNA expression and accumulation are regulated mainly at the transcriptional level (16, 17) , and several transcription factors have been shown to regulate MMP-9 transcription, including AP-1 (18) , AP-2 (19) , Ets-1 (20, 21) , c-Myc (22) , NF-κB (23) , and Sp1 (18, 23) . In particular, AP-1 has been implicated in controlling MMP-9 gene transcription (10, 24) . However, regulation of neuronal MMP-9 transcription, in particular in vivo after fear conditioning is virtually unknown.
In the present study we show that fear conditioning enhanced MMP-9 enzymatic activity follows its mRNA accumulation in different mouse brain structures pivotal for fear circuitry. Furthermore, we show that increased expression of MMP-9 mRNA is preceded by enhanced expression of c-Fos and c-Jun, major components of AP-1 transcription factor that has been implicated in MMP-9 gene regulation. Moreover, AP-1 binding was also increased after the training. Finally, we mutated the promoter sequence of mouse MMP-9 gene at four proximal AP-1 putative sites by in vitro mutagenesis and then we introduced all those reporter constructs, by means of electroporation, into the brains of newly born mouse pups aiming at the medial prefrontal cortex. As a result, we have found that two specific AP-1 binding sites in the MMP-9 gene promoter (-42/-50 and -478/-486) mediate its activation following fear conditioning. Hence, our data implicate AP-1 as a positive regulator of MMP-9 gene transcription in neurons after fear learning.
EXPERIMENTAL PROCEDURES
Subjects. The experiment was performed on adult, experimentally naive male C57BL/6 mice (25-30 g), supplied by the Nencki Institute Animal House. For 1 month before the experiment, the animals were housed in pairs in standard home cages (23.0 x18.0 x12.5 cm) with food and water provided ad libitum. The mice were habituated to the experimenter's hand for 5 days preceding the experiment. The experiment was carried out in accordance with the Polish Act on Animal Welfare, after obtaining specific permission from the First Warsaw Ethical Committee on Animal Research. All efforts were made to minimize the number of animals and their suffering.
Behavioral procedure. The mice were randomly divided into two groups (Non-shocked, NS; Shocked, S). In the behavioral experiments all animals were habituated for 3 days (one 20-min session per day) to the experimental room and marking process. The training was performed in MedAssociates fear conditioning chambers housed in a sound attenuating room. In the S group, mice were put to the experimental cages where, after 180 s of adaptation period, a single foot shock (US) was delivered (0.7 mA of 50 Hz pulses for 2 sec). Then, after 60 sec, mice were removed from the experimental cage (25) . In the NS group, mice were merely exposed to the experimental cages for an equivalent amount of time (242 sec). Then the mice were sacrificed at 0, 0.5, 2, 6, 12 and 24 h following the training/exposure. Twelve animals were used per each experimental group.
Plasmids. Mice MMP-9 gene promoter fragment -1625/+595 bp, (with first Exon & Intron, ExIn WT, 2220 bp) and -1625/+19 bp, (transcription start site, Tss WT, 1644 bp) from MMP-9 BAC vector (RP23-449M22) replaced in place of CMV promoter into a p-eGFP-N1. Here, two PCR steps were conducted by one common foreword and two different overlapping PCR primers (RF-ExIn/Tss-F: 5`-CCTGATTCTGTGGATAACCGTATTAC CGCCATGCATGCCTTGGCAGTCATGGATGT GTGTCC-3`: 65.6 0 /62.7 0 C; Exin-R: 5`-CTC GCCCTTGCTCACCATGGTGGCGATATGCCT GTGGATGGAGGAAGGGGC-3`: 65.8 0 /62.6 0 C; Tss-R: 5`-CTCGCCCTTGCTCACCATGGTGGC GAGGTGAGGACCGCAGCTTCTGGCTAA-3`: 65.8 0 /62.6 0 C; promoter sequence underlined) followed by DpnI digestion at last step (26). To enhance the GFP expression from eGFP initiation codon, point mutations were carried out in ExIn WT plasmid at Tss of MMP-9 gene by phosphorylated (*) primer pair (ExIn M-F: 5`*-CGGTCCTCACCATCAGTCCCTGGCAG-3`: 65.8 0 C,R:5`*CAGCTTCTGGCTAACGCGCCTT TGCAGAG-3`: 65.7 0 C). Point mutation in the core of four AP-1 binding motif of the MMP-9 gene promoter were generated with the sitedirected mutagenesis Kit (Thermo Scientific) according to the manufacturer's protocol using the following phosphorylated primer pairs: (AP-1a-F, 5`*-GGCGGGGTCACTGATAACGTTTTACT GCCTCT-3`: 65.7 0 C, R: 5`*-GCCTCCCCTC CAGGCTTATGCTGACTCA-3`: 65.8 0 C; AP-1b-F: 5`*-CACACACACACGCTGAGAAAGCATA AGCCTGGAGGG-3`:69 0 C, R: 5`*-TGTGTGTG TGTGTGTGTGTGTGTGTGTGTGTGTGTGTG TGTTTACA-3`: 69 0 C; AP-1c-F: 5`*-GCCAGGAGAGGAAGCTGAGAAAAAGACTC TATCAGG-3`: 66.7 0 C, R: 5`*-CTCTGGGAGC AGGCTCTTTGAGGCAGGATTTG-3`:67.0 0 C; AP-1d-F: 5`*-GGCACACAGGAGGCTTAGAAA GAACAGCTTGCTGAAG-3`:67.8 0 C, R: 5`*-AGACCTTCATGTGCTTCCCAACGAACAGAC CTGTGAG-3`: 67.8; mutated nucleotides are underlined).
General and HPLC grade oligonucleotides were synthesized by Genomed (Poland) and Metabion (Germany) respectively. All constructs were verified by DNA sequencing by Genomed (ABI377, Perkin-Elmer).
In vivo-electroporation in P0 mice pups. The WT-mmp-9-e-GFP promoter and EF-1β-galactosidase constructs were purified by Endo Free Plasmid isolation Kit (Qiagen, Hilden, Germany) and were in vivo electroporated into P0 MMP-9 wild type (WT) mice pups according to the protocol of Swartz et al. (27) . After 1 month following plasmid delivery, the mice were randomly divided into 2 groups (S and NS) and subjected to behavioral training as described earlier. After 6 hrs the mice were sacrificed, the brains were fixed and processed for either immunochemistry or GFP reporter assay. The immunofluorescence studies were carried out with anti-GFP specific primary and secondary antibodies (Santa Cruz biotechnology).
High resolution florescent in-situ zymography (ISZ). The procedure was essentially as described by Gawlak et al. (28) . The sections were dewaxed in absolute ethanol (37 °C, two times, for 5 min and 10 min, respectively). Afterwards, the alcohol was removed and slices were hydrated with phosphate buffered saline (PBS), pH 7.4, and in situ zymography was performed as follows: the specimens were first pre-incubated in water at 37 °C for 40 min, and then overlaid with a fluorogenic substrate DQ gelatin (Invitrogen/ Molecular Probes, Eugene, OR, USA) diluted 1:100 in the buffer supplied by the manufacturer, for 40 min at 37 °C. Then, they were washed with PBS and fixed in 4% PFA at room temperature (RT) for 15 min. Next, the slides were mounted directly in Vectashield (Vector, Burlingame, CA, USA) (29) . The analysis of gelatinase (green channel) were captured as single-plane of confocal images at 6-8 Z-stacks, using a 63X objective (oil immersion; 1.3 NA) with a zoom factor of six. The settings of photomultipliers were adjusted to obtain the maximal dynamic ranges of pixels in each channel. We designed an optimized program for all the images as described in image processing sections of text using macro program and run the recorded macro program for all the obtained images within ImageJ software. Using an unbiased counting frame in each picture, at each time point we estimated the mean number of objects per unit area of the tissue, the ratio of the number of objects to the number of all gelatinolyticimmunopositive objects, and the mean fluorescence intensity of the objects, defined as the product of the mean area of the localizing objects times the mean brightness. At least four animals were analyzed at each time point.
Tissue extraction and partial purification of gelatinase. Brains were rapidly removed, and the prefrontal cortex, hippocampus and amygdala were dissected separately on a cold plate. The sets of samples (S and NS) were suspended in phosphate-buffered saline (10 mM phosphate buffer pH 7.4, 150 mM NaCl) containing protease inhibitors (Sigma), minced, and incubated for 10 min at 4°C. After centrifugation at 12,000 x g for 15 min, the supernatant was collected in new centrifuge tubes marked as PBS extracts. The pellet was extracted in the lysis buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% Triton X-100 plus protease inhibitors) and centrifuged at 12,000x g for 15 min to obtain the Triton-X (TX) extract. Tissue extracts were preserved at -70°C and used later. PBS and TX extracts from all types of tissue was used for purification of gelatinase. Briefly, an extract was mixed with gelatin agarose bead, incubated at 4 o C for 1 h followed by centrifugation at 1500x g for 5 min. The pellet was washed twice with PBS through centrifugation at 1500 x g for 5 min and MMP-2 and -9 were eluted by incubating the pellet with Laemmli's sample loading buffer for 10 min at room temperature (14, 29) . Samples were equalized on the basis of the direct protein concentration measurements using the BCA method (Theremo Scientific).
Gelatin zymography. For assay of MMP-9 and -2 activities, tissue extracts were electrophoresed in 8% SDS-polyacrylamide gel containing 1 mg/ml gelatin (Sigma), under nonreducing conditions. The gels were washed twice in 2.5% Triton-X-100 (Sigma) and then incubated in calcium assay buffer (40 mM Tris-HCl, pH 7.4, 0.2 M NaCl, 10 mM CaCl 2 ) for 18 h at 37°C. The zones of gelatinolytic activity came as negative staining (14, 28) . A variation of gel-zymography using acrylamide gel copolymerized with 0.4% fluorescein isothiocyanate (FITC)-labelled gelatin. This method allows real-time monitoring of enzymatic activity under UV light and shows higher sensitivity than Coommassie staining. Quantification of zymographic bands was done using densitometry linked to proper software (Lab Image).
Fluorescent in situ hybridization (FISH) for MMP-9 mRNA combined with immunohistochemical staining. The coding sequence of MMP-9 mRNA (ATG probe) and 3`UTR (UTR probe) were reverse transcribed and cloned into a pDrive plasmid (Qiagen PCR cloning kit). Sense and antisense fluorescein labelled riboprobes were generated from plasmids with SP6 or T7 polymerase sites. For in situ hybridization studies, the animals were lethally anesthetized with sodium pentobarbital and perfused transcardially with 4% paraformaldehyde (PFA) in PBS. Brains were removed, post fixed in the same fixative, cryoprotected with 30% sucrose and snap-frozen in isopentane cooled on dry ice. The staining was performed on 40 μm-thick freefloating sections. Acetylation buffer (0.1 M triethanolamine, 0.25% HCl, 0.25% acetic anhydride) was applied for 15 min in RT. Next, sections were prehybridized for 3 hours in prehybridization solution (Sigma-Aldrich) followed by overnight hybridization at 72 °C in hybridization solution (Sigma-Aldrich) containing 1:1 mix of ATG and UTR sense or antisense probes. Afterwards, cells were washed in 0.2x SSC, with first two washes carried out for an hour in 70°C, then five consecutive washes for 30 min in RT. After then, TNB blocking solution (TSA Plus System, Perkin Elmer) was applied for an hour (30) . Cells were incubated with, mouse anti-MAP-2 antibody (Sigma) 1:200 overnight in 4°C, washed with PBST and incubated with secondary antibody, 1:1000 Alexa 488-conjugated antimouse IgG (Invitrogen) and mounted in vectashield after nuclear specific TO-PRO staining (Vector Laboratories). Cells were also incubated with anti-c-Fos and anti-P-c-Jun specific antibodies (Santa Cruz) 1:200 overnight in 4 o C, washed with PBST and incubated with secondary antibody, 1: 1000, alexa 488 conjugated antimouse IgG (Invitrogen) and mounted in vectashield after nuclear specific TO-PRO staining (Vector Laboratories). Hybridization signal was amplified with Cy3 TSA plus System (Perkin Elmer). The analysis of MMP-9 mRNA localization (red channel) were captured as singleplane of confocal images of 6-8 Z-stacks, using a 100X objective (oil immersion; 1.3 NA) with a zoom factor of three. Images were processed as described previously in "Methods".
RNA extraction. Total cellular RNA was extracted with TRIzol reagent according to the protocol provided by the manufacturer and quantified by measuring the absorbance at 260nm. Complementary DNA was synthesized using 1µg of total RNA from each sample in a 20µl reaction buffer using Superscript II Reverse Transcriptase with an oligo (dT) 15 primer (-24).
RT-PCR. Complementary DNA was amplified against forward and reverse primers of MMP-9 (Foreward, F: 5`-CTTCTGGCGTGTGAGTTTCC A-3`; Reverse, R: 5`-ACTGCACGGTTGAAGC AAAGA-3`), eGFP (F: 5`-GTCCAGGAG CGCACCATCT-3`; R: 5`-GCTTGTGCCCCAG GATGTT-3`), c-Fos (F: 5`-TTCCCCAAAC TTCGACCATG-3`; R: 5`-TGTGTTGACAGGAG AGCCCAT-3`), c-Jun (F: 5`-CATGCTAACGCA GCAGTTGC-3`; R: 5`-ACCCTTGGCTTCAGT ACTCGG-3`) and GAPDH (F: 5`-TGCCCCCAT GTTTGTGATG-3`; R: 5`-GGTCATGAGC CCTTCCACAAT-3`) respectively. The reactions were subjected to denaturation (94°C for 30 s), annealing (60°C-61.5°C for 30 s), and extension (72°C for 60 s) for 35 cycles (24, 29,) . The PCR products were fractionated on 2 % agarose gels and visualized by ethidium bromide staining.
Real time. PCR The real time-PCR was carried out in a 20 μl volume in optical 96 well reaction plates containing 2 μl cDNA, 10 pmoles of each primer and 10 μl SYBR green PCR master mix with Real-Time PCR System 7300 (Applied Biosystems, CA, USA). Taq-DNA polymerase activation was done at 95°C for 10 minutes followed by 40 cycles at 94°C for 30 seconds, 62°C for 30 seconds and 72°C for 30 seconds. A quantitative measure of MMP-9, GFP and GAPDH transcription were obtained through amplification of all cDNA in each sample at individual time points by MMP-9, GFP and GAPDH specific primer pairs as described in previous method. For performing the regulatory quantitative measure real time PCR were conducted in AP-1 specific primers (cFos and cJun) against GAPDH primers as described as before. The amount of all mRNA expressions were quantified relative to the total amount of cDNA was calculated as ΔCt=CtMMP-9/GFP/ cFOS/ cJUN-CtGAPDH where Ct of all genes and CtGAPDH were fractional cycle number at which fluorescence generated by reporter dye exceeds fixed level above baseline for all cDNA respectively. The changes of relative mRNA expressions in respective samples were expressed as ΔCt NS versus ΔCt S values. Relative expressions in all genes in respective samples were calculated as 2 -ΔΔCt (-29). GFP reporter assay. Enhanced green fluorescent (eGFP) activity was evaluated using GFP Assay System with Reporter Lysis Buffer (Biovision) or β-galactosidase assay. We followed protocols included to these kits. Results were recorded using Luminometer Model 2030-000 (Turner Biosystems) and presented in ng/μL GFP as a standardized light intensity which is a relative value obtained after normalization of β-galactosidase bioluminescence to GFP bioluminescence (31) .
Immunocytochemistry. Free floating 40 μm brain sections obtained from mice perfused transcardially with 4% paraformaldehyde were dipped overnight for permanent fixation, and then permeabilized in 1×PBS containing 0.1% Triton X-100. The cultures were blocked with 10% normal donkey serum for 1 hour at room temperature and stained with mouse anti-GFP (Santa Cruz, 1:500), primary antibodies overnight at 4°C. GFP staining was detected using donkey anti-mouse AlexaFluor 488 conjugated antibody (Invitrogen; 1:1000). For binding of secondary antibody, cultures were incubated for 2 hours at room temperature. Finally, cell nuclei were stained with TO-PRO (Vector Laboratories) and examined by the confocal microscopy (24, 28) .
Western blotting. Equal amounts of the samples were separated by 10% SDS-PAGE electro-phoresis in Tris-glycine running buffer (25 mM Tris, 250 mM glycine, pH 8.3, 0.1% SDS) and transferred to a polyvinylidene difluoride membrane (Millipore) in transfer buffer (48 mM Tris, 39 mM glycine, 0.037% SDS, 20% methanol). Membranes were stained with Ponceau red solution to check for equal protein transfer. Then, membranes were rinsed and blocked in 5% non-fat milk/TBST (25 mM Tris-HCl, pH 8.0; 125 mM NaCl; 0.1% Tween 20) for 2 hours at room temperature. Then, membranes were incubated with an appropriate primary antibodies, i.e., GAPDH (Millipore) and β-dystroglycan from Santa Cruz Biotechnology, diluted 1:300 at 4 °C overnight, and horseradish peroxidase (HRP)-conjugated secondary antibody IgG (Vector) was added at dilution of 1:5000. Results were developed using ECL PlusTM reagent (Amersham Biosciences) on an X-ray film (Kodak) (28) .
Electrophoretic mobility shift assay (EMSA). For EMSA probe we used the following double-stranded oligonucleotide containing the foot printed AP-1 motif from mouse MMP-9 gene promoter (AP-1 binding site is underlined): GCGGGGTCACTGATTCCGTTTTACTGCCT. We prepared a double-stranded oligonucleotide probe by annealing equimolar amounts [10 μM] of complementary singlestranded oligonucleotides in a solution containing 0.1 M Tris-HCl (pH 7.5), 0.5 M NaCl, 0.05 M EDTA. Oligonucleotides were placed at 65 °C for 10 min, slowly cooled down to room temperature and then kept at 4 °C overnight (-24). Double-stranded oligonucleotides (100 ng) were end labeled with (Biotinylated probe) according to the manufacturers protocol (Thermo scientific) and purified with NucTrap Probe Purification Columns (Stratagene). Binding reactions were performed in a 10 μl volume as described in manufacturer's instruction (Thermo Scientific). Immediately before loading on the gel, the samples were mixed with an ice cold 5xgel loading buffer (2xTris-glycine buffer, 50% glycerol, 0.2% bromophenol blue). Protein-DNA complexes were resolved by electrophoresis on nondenaturing 8% polyacrylamide gel in 1xTris-glycine buffer and were visualized by chemiluminescence procedure (Thermo Scientific).
EMSA supershift. For EMSA supershift assay we used the following antibodies from Santa Cruz Biotechnology: c-Jun (sc-7481X), c-Fos (sc-52X), P-c-Jun (sc-48X) and normal rabbit IgG. Binding reaction was performed as described previously (32) . Immediately before loading of samples on the gel we add ice cold 5 × gel loading buffer (2 × Tris-glycine buffer, 50% glycerol, 0.2% bromophenol blue). Double stranded oligonucleotides (100 ng) were end labeled with biotinylated probe according to the manufacturers protocol (Thermo scientific) and purified with NucTrap Probe Purification Columns (Stratagene). Protein-DNA complexes were resolved by electrophoresis on nondenaturating 8% polyacrylamide gel in 1 × Tris-glycine buffer and were visualized by chemiluminescence procedure (Thermo Scientific).
Image processing. For final inspection, the images were processed using ImageJ program (http://rsb.info.nih.gov/ij). Quantification of gelatinase activity was performed using standard functions of the ImageJ program. Briefly, multichannel image-stacks were collected at high resolution (72 nm/pixel), threshold in each channel, and segmented into individual threedimensional objects. These corresponded to the foci of gelatinolytic activity (green channel) and the dots of mRNA localization (red channel) from cell body plus neuropils. The numbers of individual objects, as well as the total numbers of objects, and the mean brightness of objects were counted automatically in three dimensions. In each animal, four stacks with whole image over the area of interest including the nucleus were analyzed in each brain picture, rendering 1200-1400 positive area/animal (28) .
Statistical analyses. Data are presented as the mean ± SEM. Significance was calculated using the Student's Newman`s Keuls test and one way ANOVA analysis by Graph Pad Instat-3 software (Germany, 29).
RESULTS:
Enhanced MMP-9 activity and subsequent β-dystroglycan cleavage in the mouse brain are associated with fear conditioning. To explore ECM remodeling by gelatinases in the mouse brain following fear conditioning, we performed high-resolution fluorescent in situ zymography (ISZ). This method allows visualization of structural details up to the resolution limit of the light microscopy. We used this technique to reveal and quantify gelatinolytic activity in the brains of mice exploring novel environment (NS) versus mice exposed to a footshock in a novel context (S). The gelatinolytic activity was studied at different time points following the training/exposure in the three major brain structures implicated in fear learning, i.e., the medial prefrontal cortex, hippocampus and amygdala (Fig. 1) . The gelatinase activity was observed in the major subdivisions of the hippocampus, especially in the pyramidal cell layers of CA1 (middle panel of Fig. 1A ) and CA3 and the granule cell layer of the dentate gyrus, DG (data not shown). Other structures within the limbic system, such as the medial prefrontal cortex (mPFC) (upper panel of Fig. 1A ) and the basolateral nucleus of the amygdala (BLA; lower panel of Fig. 1A) were also found to express gelatinase activity. The histogram in Fig 1B  depicts that overall gelatinase activity was significantly increased in the S group in comparison with the NS group at 2h-12h time points. It is evident from Fig. 1B that gelatinase activity was increased by ~15-20 folds at ~2-6 hrs time points in all investigated subdivisions of the mouse brain following fear conditioning and then gradually decreased to the basal level at 24 hrs.
Next, we investigated the enzymatic activity levels of two major gelatinases, i.e., MMP-2 and MMP-9, with gel zymography that allows deciphering molecular identity of the enzymes. The results ( Fig. 2A) confirmed that fear conditioning induced an increased gelatinase activity in all three brain structures under study and, furthermore, revealed that MMP-9 was the major inducible enzyme. The quantification of this result is provided in Fig. 2B . Herein, except for the prefrontal cortex, in both the NS and S groups the basal levels of MMP-2 expression and activity were not changed significantly ( Fig. 2A) . Histogram in Fig. 2B reveals that MMP-9 activities were increased by ~60, 50 and 40 folds respectively at 2, 6 and 12 hrs, respectively following fear conditioning.
Furthermore, we used an indirect method to measure MMP-9 activity, employing its ability to cleave its native substrate, β-dystroglycan (33) . The cytosolic extracts from both the NS and S groups of mice were subjected to Western blotting with β-dystroglycan and GAPDH specific antibodies. The level of β-dystroglycan cleavage was higher after fear conditioning (Fig. 2C ), in parallel with enhanced MMP-9 activity (compare Fig. 2B and 2D) . Herein, the β-dystroglycan cleavage was increased at ~2-12 hrs that paralleled expression of MMP-9 activity (Fig. 2D) . The overall cleavage of 30 kD molecular weight product of β-dystroglycan was enhanced by ~4-12 fold at 2-12 hrs and then gradually diminished at 24 hrs (Fig. 2D) .
MMP-9 gene expression after fear conditioning involves AP-1 transcription factor.
To investigate the cellular localization of MMP-9 mRNA expression, NS and S group of mice were subjected to in situ hybridization at three specific time points (0, 2 and 24 hrs) with MMP-9 specific mRNA probe. We observed that the localization of MMP-9 mRNA was confined to the major subdivisions of hippocampus, especially in the pyramidal cell layers of CA1 (middle panel of Fig.  3A ). Other structures associated with higher levels of MMP-9 mRNA localizations were mPFC (upper panel of Fig. 3A ) and the BLA (lower panel of Fig. 3A) . The histogram in Fig 3B depicts that overall MMP-9 mRNA accumulation was significantly increased ~15 fold in the S group in comparison with the NS group at 2 hrs time point.
Next, we asked whether fear learning affects MMP-9 mRNA levels in the all the above mentioned areas of brain tissues. With an aid of real time-PCR approach, we found that fear conditioning induced a sharp increase of MMP-9 mRNA levels (~15 fold) at 2 hrs, subsequently followed by a decline at later time period (Fig.  3C ). Since AP-1 transcription factor composed of c-Fos and c-Jun protein has been implicated in MMP-9 gene regulation (10) we performed also real time PCR analyses of c-fos and c-jun mRNAs in both the NS and S groups (Fig. 3C) . We found that expression of both mRNAs was transiently upregulated by fear training in all three brain structures investigated at 0.5-2 hrs, thus preceding the MMP-9 mRNA upregulation.
Structure of the mouse MMP-9 gene and associated AP-1 regulatory elements. Screening of the genomic libraries from both UCSC and ENSEMBL genome browser yielded multiple BAC clones, one of which (RP23-449M22; 180 kB) was purchased from BACPAC resources (Oakland, California), contained the entire 7.7-kilobase gene, as well as ~110 and ~50 kb of the 5` and 3`end flanking regions, respectively. The transcription initiation site, as determined by primer extension, revealed a double start site located 18 and 19 bp upstream of the translated sequence (data not shown; Fig. 4 ). There is a TATA box-like motif TTAAA at positions -25 to -30 but no CCAAT box prior to transcription start site (Tss). There are three GC boxes that may serve as binding sites for the transcription factor Sp1 (located at positions -57 to 62, -460 to 465, and -604 to -609). Four AP-1-like binding sites were also identified (-45 to -52, -83 to -90, -480 to -487, and -1060 to -1067). Two of those correspond to similar sequences in the human or rat gene, but sites corresponding to the first one (-45 to -52) and the most upstream one have not been reported in the human or rat gene. The conserved sequences of AP-1 sites are as follows (consensus:
TGAG(/C)TCA; mouse: TGATTCCG; rat: TGAGTCAG and human: TGAATCAG).Four conserved sequence elements with similarity to the polyoma virus enhancer Abinding protein-3 sites were found in the 5` flanking sequence, as well as in the first intron (Fig. 5) . One consensus sequence (5`-CCCCAGGC-3`) for AP-2 (-596 to -603), several microsatellite segments of alternating CA residues, as well as one NF-κB motif (-534 to -542) were also present. A putative tumor growth factor-b1-inhibitory element found in the human gene was absent in the mouse promoter.
The -43/-50 bp and -486/-479 bp motifs of mouse MMP-9 gene promoter are responsible for MMP-9 gene promoter activity after fear learning.
To explore the molecular mechanism of MMP-9 transcription in vivo, LacZ reporter gene under control of EF1α promoter and mouse WT-mmp-9-e-GFP reporter eGFP were co-electroporated at equimolar ratio, i.e., 2 µl (3-4 µg/µl) in P0 mice pups. This approach allows introducing the transgene into the cortical regions of the mouse brain (the medial prefrontal cortex). The mice were then reared up to one month of age and groups of mice were subjected to fear conditioning or cage exposure as mentioned earlier. For standardization we also incorporated both peGFP-N1 and reporter MMP-9 BAC in the prefrontal cortex of mammalian brain and thereafter subjected the mice to pentylenetetrazole (PTZ)-evoked seizure episode (see Rylski et al., 2008, (24) ; data not shown). Both groups of mice (NS and S) were sacrificed 2 hrs following fear conditioning or exposure to the context, and processed for immunostaining with e-GFP specific antibody (green) and TOPRO specific nuclear stain (blue, Fig. 5B) . Notably, we did not observe GFP expression in the NS mice, indicating that MMP-9 gene promoter was specifically activated by fear learning. Furthermore, we analyzed the MMP-9 mRNA levels by RT-PCR and real time PCR analyses, and observed parallel expression of mRNAs of both endogenous MMP-9 and exogenous MMP-9 promoter-driven GFP in vivo (Fig. 5B & C) . The results shown in Fig. 5B indicate that 2 hours after the training in the S group, the eGFP mRNA expression was enhanced ~12 fold and was paralleled by the endogenous MMP-9 mRNA expression in vivo (increased ~14 fold) as compared with the NS group. GAPDH specific RT-PCR was run as an endogenous control in the same experiment. In order to explore the regulatory mechanisms of the MMP-9 gene by AP-1 transcription factors after fear learning, we introduced the mutated versions of different promoter-reporter constructs into the medial prefrontal cortex of P0 mice pups and subjected these mice to fear conditioning (Fig. 5D) . The constructs containing exon1 had a mutation in the ATG initiator codon for translation (ATG-ATC) allowing translation of the transcript to start from the ATG methionine initiator codon in the eGFP gene. Intron 1 was included in some of the constructs, since it has been shown to contain enhancer elements. In the NS group, any mutation of the AP-1 binding site did not change significantly the MMP-9 gene promoter activity as compared to its wild type (wt) equivalent. On the other hand, 2 hours after the training in the S group, activity of the MMP-9 gene promoter mutated at -45/-52 bp site (AP-1a) was decreased significantly by ~75% and mutated at 480/-487 bp site (AP-1c) was decreased by ~25%, comparing to its wt counterpart (Fig. 5E) . Thus, it appears that both -43/-50 bp and -486/-479 bp motifs of MMP-9 gene promoter exert positive influence onto the activity of the regulatory DNA fragment during fear conditioning.
Finally, we analyzed, with an aid of an electrophoretic mobility shift assay (EMSA), the capacity of protein extracts to bind to the AP-1 specific consensus sequence of MMP-9 gene promoter. The 5` biotin labeled DNA probe composed of a sequence encompassing the mice MMP-9 gene promoter flanking at -43/-50 bp AP-1 cis-acting element, was incubated with nuclear protein lysates from the medial prefrontal cortex, hippocampus and amygdala obtained at 0, 6 and 12 hrs after the behavioral training (Fig. 6A) . To check for the specificity of the bands we performed the assay in the presence of 10-fold excess of the unlabelled probe (data not shown). Since the two uppermost protein-DNA complexes disappeared in this competition experiment, we concluded that these bands represented specific DNA-protein interactions. As a result, we observed much stronger binding of protein-DNA complex in the S group than in the NS group at 6-12 hrs after the training, indicating the DNA binding activity by AP-1 complexes during MMP-9 transcription in vivo.
To test whether AP-1 proteins can bind to the AP-1 binding region (GCGGGGTCACTGATTCCGTTTTACTGCCT), we incubated prefrontal cortex, hippocampal and amygdalar nuclear protein lysates, obtained at 2 hours following footshock, with antibodies specific against c-Fos, c-Jun and P-c-Jun proteins, and then subjected for EMSA supershift assay. We observed strong supershifts with antibodies directed against both c-Fos and P-c-Jun proteins, and slighty weaker supershift with anti-c-Jun antibody (Fig. 6B) . The supershifted bands were not observed when a control antibody was used (Fig. 6B) .
To visualize c-Fos and phosphorylated cJun proteins in the different compartments of the mouse brain (PFC, Hipp and Amy) and to confirm induction of its expression after fear conditioning, we immunostained the brain sections obtained from the animals 2 hours after Shock and Non Shock exposures. We have found that both c-Fos and c-Jun were strongly upregulated 2 hours after the shock, whereas no noticeable increase in the protein level was observed in the Non Shock group (Fig. 7A and 8A) .
After the shock, c-Fos and c-Jun was expressed mainly throughout the neuronal cell body layers of the PFC, Hipp and Amy (Fig. 7A  and 8A) . Moreover, MMP-9 mRNA distribution in the Cg1, CA1 and BLA co-localized with both cFos and P-c-Jun proteins, supporting the hypothesis about MMP-9 transcriptional regulation by c-Fos and P-c-Jun proteins (Fig. 7B  and 8B) .
DISCUSSION
In the present study, we established the fear conditioning-evoked expression pattern of MMP-9 mRNA and enzyme activity in three major mouse brain structures implicated in fear learning. We have identified AP-1 transcription factor as an important regulator of MMP-9 gene transcription and, furthermore, we showed that cFos and phosphorylated c-Jun (AP-1 components) are involved in regulation of MMP-9 expression. To achieve those results we have applied a collection of cellular, molecular and behavioral approaches, including EMSA, EMSA-supershift, immuno-FISH, as well as in vivo electroporation coupled gene reporter assay.
We showed that contextual fear conditioning results in enhanced expression of AP-1 transcription factor and its components especially c-Fos and c-Jun proteins, and that MMP-9 gene expression is activated in AP-1 dependent manner. In consequence, there is following increase in MMP-9 activity observed in the same brain areas. Our data strongly support the notion about the positive influence of AP-1 composed of c-Fos and c-Jun proteins onto MMP-9 transcription. Notably, we have employed a novel approach, using gene reporter constructs introduced into the prefrontal cortex by neonatal electroporation. This in vivo electroporation coupled gene reporter assay was, to the best of our knowledge, used for the first time for in vivo gene regulation study in learning. The promoter sequence of mouse MMP-9 gene derived from a BAC was selectively mutated at four proximal AP-1 putative sites and the regulation of MMP-9 transcription was studied in the medial prefrontal cortex after contextual fear conditioning in the adult animals. As a result, we have found that two putative AP-1 binding sites (-42/-50 and -478-486) of the WT-MMP-9 gene promoter are involved in MMP-9 transcription during learning process.
It has been established that the prefrontal cortex, hippocampus and amygdala regulate the formation, extinction and renewal of fear memories (1, 33-35) . However, the molecular mechanisms underlying synaptic plasticity in these structures are poorly understood. In particular, proteolytic activities capable to reorganize extracellular matrix in those areas have not sufficiently been explored. Many extracellular proteases that modulate the turnover of neuronal extracellular matrix, by cleaving the substrate proteins, have recently been implicated in fearrelated plasticity (5) (6) (7) (8) . In the present study we observed that overall gelatinase activity was increased in the medial prefrontal cortex, hippocampus and amygdala after fear conditioning, in comparison to the animals exposed to the experimental context but not subjected to fear conditioning. Furthermore, we demonstrate that amongst the gelatinases, the gene expression and enzymatic activity of MMP-9, but not MMP-2, have been increased.
It has been demonstrated that the local synthesis, expression and activation of MMP-9 protein in neurons is rapid and may occur already within minutes after the neuronal stimulation (14, 24, 29, 33, 36) . The present study reveals protracted MMP-9 activation at later time-points. To explain this phenomenon, we may suggest that after initial (occurring within minutes) behavioral training-driven MMP-9 release and loss in the extracellular space, there is a need for the second wave of MMP-9 transcription and associated translation, in order to replenish this lost pool of the enzyme (7) . Considering the available data it might be of great interest to further pursue a question whether observed MMP-9 transcription contributes to consolidation of fear long-term memory or whether it is a metaplastic change that impacts on later learning/memory formation.
We found that upregulated MMP-9 enzymatic activity coincided with enhanced β-DG cleavage. The localization of β-DG in various cell compartments in the brain, including dendritic spines, had already been established (37) (38) (39) . Previously, the co-existence of MMP-9 and β-DG in vivo, by high resolution double immunogold labeling was demonstrated (33) . The subcellular co-localization of β-DG and MMP-9 is consistent with the idea that MMP-9 could be secreted to the extracellular space, allowing for a focal, MMP-9-mediated proteolysis of membrane-bound β-DG. In our present report, we found both the MMP-9 enzymatic activity and β-DG cleavage in Triton X-100-soluble fraction from all the associated compartments of the fear-related brain structures, which might reflect enzymatic activation of a pool of membrane-bound MMP-9 and cleavage of membrane bound β-DG substrate.
Earlier ex vivo and in vivo studies revealed that, in non-stimulated neurons in culture, as well as in the hippocampus, noticeable levels of the truncated form of β-DG could be found. These may be due to basal activity of either MMP-2 or MMP-9, as both proteases can cleave β-DG (40, 41) . Furthermore, of special note from the previous study (33) is the finding that β-DG processing is a fast and transient phenomenon as within 20 min. after the stimulation, a decrease in the level of the 30-kDa form has been observed. Herein, in the NS group we demonstrated a mild enhancement of β-DG cleavage, which was much lower than that of the S group. This result suggests that fear conditioning results in excessive β-DG cleavage (by ~10-15 folds), while exposure to a novel context evokes less robust synaptic plasticity and, thus, moderate β-DG cleavage.
To explore the MMP-9 transcriptional mechanism following fear conditioning, we isolated the mRNA from both the S and NS groups and performed real time PCR. We observed that fear conditioning resulted in an increased transcription of MMP-9 gene (but not MMP-2 gene) as soon as 2 hrs after the training. Moreover, we found that transcription of c-Fos and c-Jun preceded MMP-9 transcription in vivo supporting an idea that AP-1 transcription factor may play a role in MMP-9 gene regulation in activated neurons (10) . To confirm that indeed AP-1 regulates MMP-9 gene transcription after fear conditioning, we have applied various approaches in vivo, including EMSA and eGFP-reporter assay after neonatal brain electroporation driven incorporation of WT and mutated versions of AP-1 motifs of mouse MMP-9 gene. The results of our study strongly support a notion of positive influence of AP-1 transcription factor, possibly composed of c-Fos and c-Jun proteins, on the MMP-9 gene transcription. Both positive and negative transcriptional regulations of MMP-9 gene by AP-1 complex were shown before in various cell types under physiological and pathological conditions (24, 42, 43) . However, the present study provides novel findings about the positive regulation of MMP-9 in a context of physiological neuronal plasticity, i.e., during fear learning.
In the mouse MMP-9 gene regulatory regions we have identified four functional AP-1 binding motifs that are located at positions at -45 to -52, -83 to -90, -480 to -487, and -1060 to -1067 upstream the transcription start site. In this report, we individually and in different combinations mutated all the above mentioned AP-1 motifs by in vitro mutagenesis and thereafter electroporated them in the medial prefrontal cortical neurons in P0 pups in vivo. The in vivo promoter activation data, as evidenced from the GFP reporter assay, revealed that after fear conditioning mainly the -45 to -52 motif and moderately at -480 to -487 motif, but not in the -83 to -90 and -1060 to -1067 AP-1 motifs drove MMP-9 gene activation. This is a controversial finding, as the other motifs of AP-1, especially the -88/81 motif, were previously shown to positively affect MMP-9 gene promoter activity (both basal and/or inducible) in various cells (44) (45) (46) . Although opposite results were also reported (20, 47, 48) . Importantly, it has also been noted that the AP-1 binding motif is essential for passive (24, (49) (50) (51) and active (52) regulation on MMP-9 gene transcriptional repression. Our results are novel because they indicate that AP-1 positively induces MMP-9 gene transcription following fear conditioning. Furthermore, they provide the first indication of AP-1 dependent activation of MMP-9 gene transcription in neurons in vivo in mammalian brain after behavioral training. It shall be also noted that mutation of all four putative AP-1 binding sites in the MMP-9 gene regulatory region did not abolish entirely the fear conditioning-evoked gene expression, suggesting that other than AP-1 transcription factors play a role in this learning.
Previously, Rylski et al. (24) showed the repressive influence of the AP-1 motif onto MMP-9 gene expression after seizure induced by PTZ or kainate in rats. We hypothesize that various putative AP-1 motifs in MMP-9 promoter might be essential for a fine tuning (activation or repression) of MMP-9 gene transcription at different physiological and pathological conditions. Since variable ratios of Fos-Jun dimeric complexes are needed in those conditions, they might regulate MMP-9 transcription to affect synaptic plasticity.
In conclusion, the observations reported herein show that MMP-9 gene transcription and associated proteolytic activity following fear conditioning depends on the tight regulation and fine tuning by the AP-1 transcription factor. Enhanced expression of c-Fos and c-Jun dimeric AP-1 protein complex positively regulates MMP-9 transcription during contextual fear learning. This is the first indication of AP-1 dependent activation of MMP-9 gene transcription in neurons during learning and memory formation in mammalian brain. The present results contribute to a growing body of evidence that MMP-9 plays crucial roles in physiological synaptic plasticity. Furthermore, our data also decipher the molecular mechanism of the MMP-9 gene transcription in the brain structures involved in fear learning in a physiological context. nucleotides starts at the transcription initiation site. The TATA motif, GC boxes, AP-1-like, AP2, polyoma virus enhancer A-binding protein-3, and NF-kB binding consensus sequences are boxed. Alternating CA-rich sequences are underlined. Mouse MMP-9 gene promoter fragment -1625/+595 bp, (with first Exon & Intron, ExIn WT, 2220 bp) and -1625/+19 bp (transcription start site, Tss WT, 1644 bp) from MMP-9 BAC vector (RP23-449M22) were put in place of CMV promoter into a p-eGFP-N1 plasmid by restriction free (RF) cloning. In the core of AP-1 binding motif (blue marked 8bp region) of the MMP-9 gene promoter AA sites were replaced by site-directed mutagenesis according to the manufacturer's protocol using the phosphorylated primer pairs. Equal concentrations (0.6μg) of cDNA were used for RT-PCR analysis of MMP-9 and GFP specific mRNA probe relative to GAPDH specific mRNA probe. (E) The medial prefrontal cortex of P0 pups were electroporated with different combinations of WT and mutated versions (with AP-1 motifs) of mouse MMP-9 GFP reporter plasmid and β-gal plasmid with EF1 promoter and were harvested after one month. (F) The histogram shows MMP-9 gene promoter activity in the medial prefrontal cortex of the S and NS animals which were previously co-electroporated with combination of a WT or mutated versions of the reporter plasmids bearing eGFP gene under control of a wild type MMP-9 mouse gene along with β-gal plasmid under control of EF-1 promoter. The brains were harvested after 2 hours following the training/exposure and subjected to GFP assay. Results are reported as the means ± SEM, *p<0.001 versus the NS group. FIGURE 6. Increased binding of nuclear c-Fos and P-c-Jun proteins at AP-1 cis-element of MMP-9 promoter during fearlearning. The figure showing EMSA assay, where in vitro binding of mouse nuclear extracts from (A) the prefrontal cortex, hippocampus and amygdala to the consensus AP-1 binding motif at -43/-50 bp of MMP-9 gene promoter depends on the training conditions being strongly enhanced by fear conditioning. The binding of proteins extracted from the unstimulated novel cage exposure in NS group of mice shown in a lane marked as the NS whereas, animals exposed to foot shock is shown in the lane marked as S at respective time points. In the competition reaction, 15-fold excess of the cold, wild type probe was used. (B) EMSA supershift assay was done after 2 hours of post shock revealed significantly stronger binding of hippocampal AP-1 components (c-Fos and P-c-Jun) to the −43/-50 bp region of mouse MMP-9 gene promoter. Control is run as a "panjun specific Isotype antibody" detecting all AP-1 components in EMSA supershift reaction. The specific band is designated as "AP-1" which is specifically formed due to the DNA fragment interaction with AP-1 components and the supershifted band is marked by the arrow specified as "SS". Immunohistochemical staining for c-Fos (in green) and in situ hybridization for MMP-9 mRNA (in red) were performed in the same brain section. Cell nuclei are stained with TO-PRO (in blue). Scale bar equals 10 μm. FIGURE 8. Expression of P-c-Jun protein enhances the transcription of MMP-9 in the mouse brain. The prefrontal cortex (PFC), hippocampus (Hipp) and amygdala (Amy) of mouse brain 2 hours after contextual fear conditioning (S) and exposure to the experimental cage (NS). Induction of P-c-Jun expression is limited mostly to the neuronal cell nuclei and overlaps with a distribution of MMP-9 mRNA. (A) Immunohistochemical staining of P-c-Jun with a distribution of MMP-9 mRNA, showed in green and red respectively, is induced in the PFC, Hipp and Amy cell nuclei in the NS and S groups. Cell nuclei are stained with TO-PRO (in blue). Scale bar equals 1 mm. (B) 2 hrs after the training, P-c-Jun expression overlaps with MMP-9 mRNA in the Cg1, CA1 and BLA of the mouse brain in the NS and S groups. Immunohistochemical staining for P-c-Jun (in green) and in situ hybridization for MMP-9 mRNA (in red) were performed in the same brain section. Cell nuclei are stained with TO-PRO (in blue). Scale bar equals 10 μm.
